Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

PURPOSE: Guiding response to neoadjuvant chemotherapy (guided-NACT) allows for an adaptative treatment approach likely to improve breast cancer survival. In this study, our primary aim is to explore the expected cost-effectiveness of guided-NACT using as a case study the first randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Miquel-Cases, Anna, Retèl, Valesca P., Lederer, Bianca, von Minckwitz, Gunter, Steuten, Lotte M. G., van Harten, Wim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849576/
https://www.ncbi.nlm.nih.gov/pubmed/27124410
http://dx.doi.org/10.1371/journal.pone.0154386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849576/
https://www.ncbi.nlm.nih.gov/pubmed/27124410
http://dx.doi.org/10.1371/journal.pone.0154386

Ejemplares similares